For those who scoff at the idea that stock markets are efficient, skepticism can be an investor's best friend. Recognizing good news (or potential) when you see it and buying in before it's commonly accepted can be a ticket to above-average performance, and that has been true for Merck (MRK) and its shareholders recently. While I've been positive on this giant Big Pharma for some time now, it seems like others on the Street have woken up to the value and potential here over the past couple of months.
Read more here:
Skepticism Could Be A Merck Investor's Friend